Wilbanks Smith & Thomas Asset Management LLC 10x Genomics, Inc. Transaction History

Wilbanks Smith & Thomas Asset Management LLC

$3.54 Billion
Q1 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 04, 2021	SELL	$134.22 - $202.37 $173,814 - $262,069	-1,295 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$140.25 - $196.86 $181,623 - $254,933	1,295 New	1,295 $234,000

Others Institutions Holding TXG

# of Institutions

291

Shares Held

94.7M

Call Options Held

263K

Put Options Held

85.1K

Vanguard Group Inc Valley Forge, PA

11M
Shares

$174 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

10.8M
Shares

$170 Million
2.31% of portfolio
Morgan Stanley New York, NY

6.48M
Shares

$102 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.39M
Shares

$101 Million
0.0% of portfolio
Nikko Asset Management Americas, Inc.

6.37M
Shares

$101 Million
1.67% of portfolio

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilbanks Smith & Thomas Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilbanks Smith & Thomas Asset Management LLC with notifications on news.

Account